🔎 Trials Near Me

Hjem › Akut lymfoblastisk leukæmi › Illinois › Chicago

Akut lymfoblastisk leukæmi kliniske forsøg i Chicago, IL

19 studier for Akut lymfoblastisk leukæmi søger deltagere på steder i og omkring Chicago (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
  • Mount Sinai Hospital Medical Center, Chicago
  • John H Stroger Jr Hospital of Cook County, Chicago
  • University of Illinois, Chicago
  • og 1 flere
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

RekruttererFase 1/2
  • The University of Chicago Medical Center, Chicago
30 Days · Alle køn · Opdateret 16. sep. 2026 · NCT04065399

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RekruttererFase 1/2
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Op til 22 år · Alle køn · Opdateret 25. aug. 2026 · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

RekruttererFase 2
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Alder 7 til 25 · Alle køn · Opdateret 19. aug. 2026 · NCT05082519

A Study of CTD402 in T-ALL/LBL Patients

RekruttererFase 1/2
  • University of Chicago, Chicago
Alder 1 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT07070219

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

RekruttererObservationsstudie
  • The University of Chicago, Chicago
1 Day – 17 Years · Alle køn · Opdateret 14. aug. 2026 · NCT06274788

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

RekruttererFase 1/2
  • Research Site, Chicago
Alder 12 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT07109219

Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia

Rekrutterer
  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
Alder 15 og opefter · Alle køn · Opdateret 10. jul. 2026 · NCT06446661

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RekruttererObservationsstudie
  • Northwestern Memorial Hospital, Chicago
  • Rush University Medical Center, Chicago
  • University of Illinois at Chicago, Chicago
  • og 2 flere
Alle aldre · Alle køn · Opdateret 6. jul. 2026 · NCT01351545

Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

Rekrutterer
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
Alder 14 og opefter · Alle køn · Opdateret 30. jun. 2026 · NCT03932903

Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia

RekruttererFase 1
  • University of Chicago Medical Center, Chicago
Alder 18 til 39 · Alle køn · Opdateret 29. jun. 2026 · NCT03571321

Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)

RekruttererFase 2
  • University of Chicago Medical Center, Chicago
Alder 18 og opefter · Alle køn · Opdateret 5. jun. 2026 · NCT04747912

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

RekruttererObservationsstudie
  • Lurie Children's Hospital-Chicago, Chicago
Alle aldre · Alle køn · Opdateret 18. maj 2026 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

RekruttererFase 1
  • University of Chicago, Chicago
Alder 13 og opefter · Alle køn · Opdateret 5. maj 2026 · NCT04771572

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

RekruttererFase 1/2
  • Northwestern, Chicago
Alder 12 og opefter · Alle køn · Opdateret 24. mar. 2026 · NCT04988555

A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

RekruttererFase 1/2
  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
Alder 18 og opefter · Alle køn · Opdateret 18. mar. 2026 · NCT06207123

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

RekruttererFase 2
  • University of Chicago Comprehensive Cancer Center, Chicago
Alder 18 til 54 · Alle køn · Opdateret 17. mar. 2026 · NCT06918431

Venetoclax Basket Trial for High Risk Hematologic Malignancies

RekruttererFase 1
  • Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Alder 1 til 40 · Alle køn · Opdateret 12. mar. 2026 · NCT05292664

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RekruttererFase 1
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Alder 1 til 21 · Alle køn · Opdateret 6. dec. 2024 · NCT05476770

Akut lymfoblastisk leukæmi forsøg i andre byer

Andre studier i Chicago

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.